In regular Pharma Readiness reports Diaceutics analyses the global marketplace for diagnostic integration, summarizing the year that's gone and making predictions for the months ahead. But given our unique position as thought leaders in the space, with inside knowledge of the diagnostic, pharmaceutical and laboratory industries, we have gone into more detail in the Ebook, Pharma Readiness for Diagnostic Integration 2017: Opinion pieces on the precision medicine and diagnostic marketplace in 2017 and beyond.
Written by Peter Keeling, CEO of Diaceutics and Jeff Waldron, Executive Director of PMConnective.org, these commentaries discuss the current and future state of the diagnostic and precision medicine marketplaces at a time when industrial, clinical and research activity is driving us with acceleration towards a long-promised transformation of healthcare delivery. Subjects include disruption in precision medicine, getting things right with PD-L1, segmentation and lack of integration.
As a discussion of the way our healthcare and business models are heading it is sure to raise some surprising and even controversial points. And if you want to delve deeper into diagnostic issues, our other Ebooks should provide plenty of thought-provoking content.
